BioSpace News Archive

AVEO Pharmaceuticals, Inc. announced that it has priced an underwritten public offering of 2,500,000 shares of common stock at a price to the public of $2.26 per share

Darryl Williams, MediSpend’s senior director analytics, will moderate a panel of leading pharmaceutical experts in a discussion of the varying degrees of analytics programs across the life sciences industry at the 12th Annual Forum on Transparency and Aggregate Spend at 2:50pm on Tuesday, August 21, 2018 in Washington, DC.

Boxing Fitness Franchise Looks to Team Up with Qualified Partners and Regional Franchise Developers in Toronto and Vancouver

Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).

KC Animal Health Corridor Investment Forum showcases latest industry innovations.

A recent publication from The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, addresses the role of community pharmacies in boosting adult vaccination rates in the United States.

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced the finalists for the first-ever MSL of the Year Awards.

At last week’s 57th Annual Meeting and ToxExpo (in San Antonio, Texas), the Society of Toxicology announced “Deconvoluting Kinase Inhibitor Induced Cardiotoxicity” as its paper of the year for 2017.

Kleresca® announced they have received CE mark approval for their technology platform.

In a research article just published in PLOS ONE, scientists at ACEA Biosciences, a biotechnology company focused on the development of high performance cell analysis instruments, investigate the efficacy of a real-time in vitro potency assay for evaluating various immunotherapy treatments against both solid and liquid tumor cells. Immunotherapy, a powerful approach in which a patient’s immune system is prompted to attack cancerous cells, continues to show tremendous therapeutic potential.